972 filings
Page 16 of 49
4
ACER
Acer Therapeutics Inc.
5 Feb 19
Acer Therapeutics / William T. Andrews ownership change
1:49pm
4
Jason Amello
5 Feb 19
Acer Therapeutics / Jason Amello ownership change
1:47pm
8-K
ACER
Acer Therapeutics Inc.
7 Jan 19
Regulation FD Disclosure
9:00am
8-K
ACER
Acer Therapeutics Inc.
2 Jan 19
Acer Therapeutics Announces In-license of Osanetant from Sanofi
9:00am
8-K
ACER
Acer Therapeutics Inc.
26 Dec 18
Acer Therapeutics Announces FDA Acceptance of NDA and Priority Review for EDSIVO™ for the Treatment of vEDS
8:59am
4
ACER
Acer Therapeutics Inc.
6 Dec 18
Acer Therapeutics / Salma Jutt-Eghbali ownership change
6:20pm
3
Salma Jutt-Eghbali
6 Dec 18
Acer Therapeutics / Salma Jutt-Eghbali ownership change
6:19pm
424B2
ACER
Acer Therapeutics Inc.
23 Nov 18
Prospectus for primary offering
6:06am
EFFECT
ACER
Acer Therapeutics Inc.
23 Nov 18
Notice of effectiveness
12:15am
CORRESP
ACER
Acer Therapeutics Inc.
19 Nov 18
Correspondence with SEC
12:00am
UPLOAD
ACER
Acer Therapeutics Inc.
16 Nov 18
Letter from SEC
12:00am
S-3
ACER
Acer Therapeutics Inc.
Shelf registration
9 Nov 18
4:28pm
8-K
ACER
Acer Therapeutics Inc.
9 Nov 18
Entry into a Material Definitive Agreement
4:25pm
10-Q
2018 Q3
ACER
Acer Therapeutics Inc.
Quarterly report
9 Nov 18
4:06pm
8-K
ACER
Acer Therapeutics Inc.
9 Nov 18
Acer Therapeutics Reports Third Quarter 2018 Financial Results and Provides Corporate Update
4:01pm
8-K
ACER
Acer Therapeutics Inc.
29 Oct 18
Acer Therapeutics Submits NDA for EDSIVO™ for the Treatment of vEDS
8:45am
8-K
ACER
Acer Therapeutics Inc.
25 Sep 18
Entry into a Material Definitive Agreement
4:00pm
SC 13G
ACER
Acer Therapeutics Inc.
17 Sep 18
Acer Therapeutics Inc.
12:00am
8-K
ACER
Acer Therapeutics Inc.
4 Sep 18
Departure of Directors or Certain Officers
12:00am
SC 13D/A
TVM Life Science Ventures VI LP
24 Aug 18
Acer Therapeutics Inc.
12:00am